We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global Advanced Wound-Management Market Experiences Growth

By HospiMedica International staff writers
Posted on 24 Nov 2009
A new report by GlobalData (London, United Kingdom) identifies and assesses the key trends shaping and driving the global advanced wound management market. More...


According to GlobalData, the global advanced wound management market was valued at U.S. $3.6 billion in 2008 and forecasts that it will grow by 4.7% annually for the next seven years, reaching $5 billion by 2015. This growth will primarily be driven by an increase in the incidence of chronic wounds such as venous, diabetic, and pressure ulcers, increased patient awareness, and technology advancement in the products themselves.

Foams and hydrofibers remain the key market segments that are driving growth within the advanced wound management market; together, these two segments accounted for 67% of the overall advanced wound management market in 2008. According to the report, the foams market is forecast to grow at a 5.4% compound annual growth rate (CAGR) till 2015, due to faster healing of certain types of wounds and reduced patient follow-up, which will limit the cost factor. The hydrofibers market is forecast to grow at 4.7% CAGR, and is expected to be driven by technological advancements and an increase in the number of diabetic patients.

Globally, the United States remains the largest advanced wound management market, and is expected to continue to be so. The U.S. market was valued at $1.5 billion in 2008 and is forecast to grow at a 4.9% CAGR, reaching a value of $2.2 billion by 2015. The U.S. market is expected to be driven by a growing chronic wound population and increased levels of patient awareness. Companies such as Smith & Nephew, Molnlycke Healthcare, Convatec, and Covidien remain the leading competitors in the global advanced wound management market; together, these companies accounted for 56% of the global market share in 2008, with Smith & Nephew (London, United Kingdom) the market leader with a share of 27%. However, with more than 35 products in different developmental stages in 2008, and many of these expected to hit the market in the next few years, a shift in the prevailing competitive landscape cannot be ruled out. If approved, these pipeline products could lead to an intensely competitive market landscape, and the existing market leaders need to be prepared to manage these future challenges.

Related Links:
GlobalData
Smith & Nephew


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.